Monday, 17 August 2026European Markets
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Platforms Move to Shore Up Trust as Leadership Shifts and AI-Adjacent Markets Wobble
Major AI and media platforms are converging on trust and accountability measures — Anthropic's Claude adding watermarks, Spotify labeling AI artists — just as OpenAI loses special-projects lead Brad Lightcap and Meta's Zuckerberg publishes a defensive manifesto on AI's societal role. In parallel, AI-adjacent financial dynamics are surfacing real stress: Wall Street firms are paying for privileged early access to Trump's Truth Social posts for trading edge, while Trump Media itself reports a $238M loss driven by falling crypto holdings, highlighting how information asymmetry and speculative digital assets are becoming entangled with AI-era platforms.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts report JPMorgan Chase & Co.'s revenue for the same fiscal period (FY 2025) with the same observation date (2025-12-31), but with different values: $182.447 billion vs. $185 billion. The ~1.4% difference ($2.553 billion) is too large to be explained by rounding alone and represents conflicting data for the identical time period.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,809
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,809 facts checked against source5,205 source documents archived
Work with this data → vianewsagency.com

METABOLIC EXPLORER Stock Was 31.81% Up Today

Loading stream...

(vianews) - the market ended the session with metabolic explorer (metex.pa) rising 31.81% to €0.49 on monday, following the last session's downward trend. cac 40 dropped 0.03% to €7,589.96, following the last session's upward trend on what was a somewhat bearish trend trading session today.

metabolic explorer's last close was €0.37, 73.89% below its 52-week high of €1.42.

about metabolic explorer

metabolic explorer s.a., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. the company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and l-valine. its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials. the company was incorporated in 1999 and is based in saint-beauzire, france.

earnings per share

as for profitability, metabolic explorer has a trailing twelve months eps of €-0.98.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -42.82%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, metabolic explorer's stock is considered to be overbought (>=80).

volatility

metabolic explorer's last week, last month's, and last quarter's current intraday variation average was a negative 1.13%, a positive 0.39%, and a positive 4.67%.

metabolic explorer's highest amplitude of average volatility was 2.81% (last week), 3.65% (last month), and 4.67% (last quarter).

moving average

metabolic explorer's value is way higher than its 50-day moving average of €0.38 and way below its 200-day moving average of €0.69.

volume

today's last reported volume for metabolic explorer is 732171 which is 401.25% above its average volume of 146067.

more news about metabolic explorer (metex.pa).